Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Thyroid Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

100 recruiting trials for Thyroid. Eligibility criteria explained in plain English.

TrialFinderData lists 100 Thyroid clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 2 is the largest group at 32% (12 studies); the largest phase groups are Phase 2: 12, Phase 1: 7, Phase 3: 6, Phase 4: 5.

Research is led by M.D. Anderson Cancer Center (4), Shanghai Changzheng Hospital (4), Fudan University (4), among the most active sponsors registered for these trials.

The most frequently studied intervention is IBI311 (drug, 3 trials), followed by CD70-targeted CAR-T cells, ultrasound-guided thermal ablation.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
6
Phase 3 Trials
10
Sponsors

Track Thyroid trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGEarly Phase 1NCT07261345

Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease

Graves' disease is an autoimmune thyroid disorder in which autoantibodies against the thyroid-stimulating hormone receptor (TRAb) lead to excessive thyroid hormone production and...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 41 location
RECRUITINGNCT03410394

Registry of Endocrine Tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube)

This registry aims to collect informations about patients with endocrine tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube) who undergo endocrine...

Sponsor: Central Hospital, Nancy, FranceEnrolling: 30001 location
RECRUITINGPhase 1 / Phase 2NCT05451602

HEC169096 in Participants With Advanced Solid Tumors

An Open, Multi-Center Phase I/II Clinical Study To Evaluate The Safety, Tolerability, Pharmacokinetic Characteristics And Effectiveness Of HEC169096 In Patients With Thyroid...

Sponsor: Sunshine Lake Pharma Co., Ltd.Enrolling: 4561 location
RECRUITINGNCT06356272

Oropharynx (OPX) Biomarker Trial

The purpose of this research is to identify a biomarker that is exists when human papillomavirus (HPV) mediated oropharyngeal squamous cell carcinoma is present and does not exist...

Sponsor: Mayo ClinicEnrolling: 5601 location
RECRUITINGPhase 1NCT04892303

Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer

The goal of this study is to evaluate combined radioactive iodine (RAI, 131-I) and external beam radiotherapy (XRT) to optimize the radiation dose delivered to treat well...

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsEnrolling: 481 location
RECRUITINGPhase 1NCT07286656

A Study of GensSci098 in Subjects With Graves' Disease

To evaluate the safety and tolerability of single ascending subcutaneous doses of GenSci098 in patients with Graves' Disease

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Enrolling: 241 location
RECRUITINGPhase 2NCT06085625

A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid Lobectomy

To compare same-day discharge and overnight (or longer) observation practices and learn more about the differences in patient preferences, safety outcomes, and economic and...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 2241 location
RECRUITINGNCT07447089

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

The main aim of the present process-outcome study is to evaluate the feasibility and the effects of an EMDR-IGTP-OTS group intervention on a sample of people with cancer, by using...

Sponsor: Università Cattolica di MilanoEnrolling: 251 location
RECRUITINGNCT02609685

Active Surveillance of Papillary Thyroid Microcarcinoma

The purpose of this study is to better understand the outcomes of active surveillance (observation) instead of immediate surgery, which is the current standard of care for...

Sponsor: Cedars-Sinai Medical CenterEnrolling: 2161 location
RECRUITINGNCT06015620

Comorbidities Resolution After MGB Surgery and Change in Body Composition

This observational study aims to learn about the correlation between the improving comorbidities associated with obesity after MGB (Mini-Gastric Bypass) surgery and changes in...

Sponsor: All India Institute of Medical Sciences, BhubaneswarEnrolling: 351 location
RECRUITINGPhase 2NCT05852223

Pembrolizumab in High-risk Thyroid Cancer

This window of opportunity trial is studying a checkpoint inhibitor agent to treat differentiated thyroid cancer in a neoadjuvant setting. A checkpoint inhibitor is a compound...

Sponsor: Istituti Clinici Scientifici Maugeri SpAEnrolling: 251 location
RECRUITINGNCT06765941

PTeye vs Surgeons Eyes in Intraoperative Identification and Functional Preservation of Parathyroid Glands During...

The goal of this randomized clinical trial is to learn if there are any added benefits of using near-infrared autofluorescence (NIRAF) probe-based imaging system (the PTeye) for...

Sponsor: Marcin BarczynskiEnrolling: 1541 location
RECRUITINGNCT07010380

Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder)

This study tests PTFinder, a dual-camera system that makes parathyroid glands glow on screen by capturing their natural near-infrared autofluorescence. After a thyroid or...

Sponsor: Bo Wang,MDEnrolling: 1801 location
RECRUITINGNCT01109420

Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer

Background: \- Researchers are studying types of thyroid cancer that seem to cluster in families. Non-medullary thyroid cancer accounts for the vast majority of all types of...

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling: 5001 location
RECRUITINGNCT07072143

An International Study on Pediatric Patients With Rare Tumors.

The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.

Sponsor: Azienda Ospedaliera di PadovaEnrolling: 62501 location
RECRUITINGNCT04845867

A Prospective, Single-arm, Multi-centre, Blinded, Observational, Diagnostic Accuracy Study With a Diagnostic Medical...

After thyroid surgery, 0.6 to 4% of patients develop postoperative bleeding. 90% of this postoperative bleeding occurs within the first 48 hours. Most of the time, the...

Sponsor: ISAR-M GmbHEnrolling: 14701 location
RECRUITINGPhase 2NCT05783323

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical...

Sponsor: Children's Hospital of PhiladelphiaEnrolling: 135 locations
RECRUITINGPhase 1NCT05355701

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07799933) administered as a single agent and in combination with other...

Sponsor: PfizerEnrolling: 26720 locations
RECRUITINGPhase 4NCT07152366

Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the...

Thyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune disease closely related to thyroid disease, which leads the incidence of orbital disease in adults and is...

Sponsor: Shanghai Changzheng HospitalEnrolling: 961 location
RECRUITINGPhase 2NCT06440850

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With...

This phase II trial tests how well vemurafenib and cobimetinib work in treating patients with high risk differentiated thyroid carcinoma with BRAFV600E mutation, in preparation...

Sponsor: City of Hope Medical CenterEnrolling: 211 location
RECRUITINGNCT06864351

Prospective Evaluation of OptiThyDose

The aim of this multicentric, randomised, two-arms and single-blinded clinical trial is to prospectively evaluate OptiThyDose for Congenital hypothyroidism (CH) and Graves'...

Sponsor: University Children's Hospital BaselEnrolling: 1502 locations
RECRUITINGNCT06421805

Establishing Prospective Mediastinal Tumor Database of PUMCH

This study aims to prospectively document the population characteristics, imaging findings, pathological features, prognostic factors, etc., of patients with mediastinal tumors....

Sponsor: Peking Union Medical College HospitalEnrolling: 20001 location
RECRUITINGPhase 2NCT06970353

Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer

This phase II trial evaluates Tunlametinib (MEK inhibitor) ± PD-1 in NRAS-mutant advanced thyroid cancer. Key Objectives: Assess efficacy (ORR by RECIST v1.1) Evaluate safety...

Sponsor: Fudan UniversityEnrolling: 401 location
RECRUITINGNCT06588764

Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy

To investigate the efficacy and safety of modified deep lateral wall decompression and/or medial wall decompression for Moderate-to-severe Grave's Ophthalmopathy.

Sponsor: Sun Yat-sen UniversityEnrolling: 501 location
RECRUITINGPhase 2NCT05989425

Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Locally advanced thyroid cancer has a wide range of surgery, large trauma and high local recurrence rate. It is one of the main causes of death in patients with thyroid cancer....

Sponsor: Fudan UniversityEnrolling: 321 location
RECRUITINGPhase 3NCT06989918

MHB018A Treatment in Patients With Active Thyroid Eye Disease

The primary objective of this study is to investigate the efficacy, safety, and tolerability of MHB018A, a humanized anti-IGF1R antibody, administered q4W for 6 months, in...

Sponsor: Minghui Pharmaceutical (Hangzhou) LtdEnrolling: 1081 location
RECRUITINGPhase 1NCT07181720

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

This study is a single-arm, open-label, dose-escalating + dose-expansion clinical study, aiming to evaluate the safety and efficacy of CD70-targeted CAR-T cell preparations, and...

Sponsor: Chongqing Precision Biotech Co., LtdEnrolling: 901 location
RECRUITINGNCT06733740

Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma

To evaluate long-term outcomes of ultrasound-guided thermal ablation for the treatment of papillary thyroid carcinoma

Sponsor: Chinese PLA General HospitalEnrolling: 30001 location
RECRUITINGNCT06333587

Minimally Invasive Treatments of the Thyroid

This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid...

Sponsor: European Institute of OncologyEnrolling: 2701 location
RECRUITINGNCT05604963

Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers

This is a multi-centre, randomised, non-inferiority, phase III study in patients with low risk differentiated thyroid cancer. Patients will be identified via oncology...

Sponsor: University College, LondonEnrolling: 45620 locations
RECRUITINGEarly Phase 1NCT07333677

In Vivo CAR-T for Refractory Graves' Disease

Graves' disease is an autoimmune thyroid disorder characterized by the production of autoantibodies against the thyroid-stimulating hormone receptor (TRAb), leading to excessive...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 51 location
RECRUITINGPhase 2NCT06458036

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical...

Sponsor: Children's Hospital of PhiladelphiaEnrolling: 134 locations
RECRUITINGNCT04693377

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME...

This trial compares cryoablation combined with stereotactic body radiation therapy to stereotactic body radiation therapy alone to see how well they work in treating patients with...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 401 location
RECRUITINGPhase 4NCT06927375

A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated...

Thyroid-associated ophthalmopathy (TAO) is a serious, progressive, vision-threatening autoimmune disease that can be categorized into mild, moderate, and severe stages based on...

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityEnrolling: 601 location
RECRUITINGNCT06738888

Renovated Prediction Model for Difficult Transoral and Submental Endoscopic Thyroidectomy

The investigators have previously proposed a prediction model for difficult transoral and submental thyroidectomy through a retrospective study. In order to better promote...

Sponsor: Shanghai 6th People's HospitalEnrolling: 3001 location
RECRUITINGNCT06236373

The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia

This qualitative study seeks to explore the unmet needs of individuals who have recently undergone a cancer diagnosis and completed the acute phase of treatment. The primary...

Sponsor: University of Modena and Reggio EmiliaEnrolling: 451 location
RECRUITINGNCT06316895

The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

1. To evaluate the clinical outcomes of ultrasound-guided thermal ablation and thyroid surgery for the treatment of papillary thyroid carcinoma; 2. To develop and validate a...

Sponsor: Chinese PLA General HospitalEnrolling: 37721 location
RECRUITINGNCT06623500

Iodine Nutrition Status and Clinical Characteristics of Thyroid Cancer

The effect of iodine nutritional status on thyroid cancer has been controversial for many years. We designed a prospective cohort study that recruiting patients in different...

Sponsor: Shandong Provincial HospitalEnrolling: 16001 location
RECRUITINGPhase 2NCT07016230

Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and...

UNLOCK TARLATAMAB is an open-label, single arm, multicenter, phase 2 platform study that aims to evaluate the mechanisms of action and resistance to tarlatamab in...

Sponsor: Gustave Roussy, Cancer Campus, Grand ParisEnrolling: 401 location
RECRUITINGNCT06730529

The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases

This study aims to investigate the value of 68Ga-FAPI in the preoperative evaluation of thyroid cancer of different pathologic types.

Sponsor: Ruijin HospitalEnrolling: 401 location
RECRUITINGPhase 1NCT07597200

A Clinical Study of Cizutamig in Thyroid Eye Disease

The purpose of this study is to evaluate the safety, tolerability, PK, PD, immunogenicity, and preliminary clinical activity of cizutamig in patients with thyroid eye disease...

Sponsor: Candid TherapeuticsEnrolling: 381 location
RECRUITINGNCT07421869

SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial

The goal of this study is to find out whether hypothyroidism caused by immune checkpoint inhibitors (ICIs) can recover after stopping the ICIs. The study also aims to identify...

Sponsor: Seoul National University Bundang HospitalEnrolling: 1071 location
RECRUITINGNCT06359795

Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease

FAPI PET has been developed as a promising approach for the evaluation of fibroinflammatory, such as in inflammatory bowel disease. This prospective study aims to explore the...

Sponsor: Peking University Third HospitalEnrolling: 501 location
RECRUITINGNCT04742608

Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid...

This study is being done to help researchers learn more about and successfully diagnose cancer using blood samples and tissue samples from surgeries in patients with suspicious...

Sponsor: Jonsson Comprehensive Cancer CenterEnrolling: 2501 location
RECRUITINGNCT07040306

A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China

This study was a prospective follow-up study of newly diagnosed and relapsed Graves' disease patients in the Endocrinology Clinic of the First Affiliated Hospital of China Medical...

Sponsor: First Hospital of China Medical UniversityEnrolling: 10001 location
RECRUITINGPhase 4NCT07152340

The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO...

Thyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune disease closely related to thyroid disease, which leads the incidence of orbital disease in adults and is...

Sponsor: Shanghai Changzheng HospitalEnrolling: 642 locations
RECRUITINGPhase 2NCT07235566

MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC

This study is a single-arm, open-label, multi-cohort, single-center phase II clinical trial designed to observe and evaluate the efficacy and safety of MRG003 (a EGFR-ADC) in...

Sponsor: Fudan UniversityEnrolling: 601 location
RECRUITINGNCT06967896

Different Models of Tracheal Catheters Are Used for Female Thyroid Glands

Objective:Compare whether the use of tracheal catheters of models 6.0 and 6.5 causes less sore throat in women after thyroid surgery compared with the traditional use of model 7.0...

Sponsor: Anqing Municipal HospitalEnrolling: 1801 location
RECRUITINGNCT06254859

Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery

This study examines the impact of intraoperative recurrent laryngeal nerve monitoring signal changes on the postoperative voice quality of thyroid surgery patients. By analyzing...

Sponsor: Fujian Medical UniversityEnrolling: 1001 location
RECRUITINGNCT05713123

Comparison of Record in VERITON Camera to the Anger Camera Procedure in Patients Treated by 131-iodine

The aim of this study is to show that the SPECT/CT whole body recording procedure lasting less than or equal to 30 minutes in a VERITON-CT™ camera, can be substituted for the...

Sponsor: Central Hospital, Nancy, FranceEnrolling: 771 location

Showing 50 of 100 trials.Search all Thyroid trials

Frequently Asked Questions

There are currently 100 clinical trials for Thyroid, with 100 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Thyroid, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 6 Phase 3 trials for Thyroid, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.